BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15078907)

  • 1. Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer.
    Matsumoto H; Wada T; Fukunaga K; Yoshihiro S; Matsuyama H; Naito K
    Jpn J Clin Oncol; 2004 Mar; 34(3):124-30. PubMed ID: 15078907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.
    Ong F; Moonen LM; Gallee MP; ten Bosch C; Zerp SF; Hart AA; Bartelink H; Verheij M
    Radiother Oncol; 2001 Nov; 61(2):169-75. PubMed ID: 11690683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer.
    Matsumoto H; Matsuyama H; Fukunaga K; Yoshihiro S; Wada T; Naito K
    Br J Cancer; 2004 Sep; 91(6):1025-31. PubMed ID: 15292937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation.
    Rödel C; Grabenbauer GG; Rödel F; Birkenhake S; Kühn R; Martus P; Zörcher T; Fürsich D; Papadopoulos T; Dunst J; Schrott KM; Sauer R
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1213-21. PubMed ID: 10725634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis in transitional cell carcinoma of bladder and its relation to proliferation and expression of p53 and bcl-2.
    Amirghofran Z; Monabati A; Khezri A; Malek-Hosseini Z
    Pathol Oncol Res; 2004; 10(3):154-8. PubMed ID: 15448751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
    Wolf HK; Stöber C; Hohenfellner R; Leissner J
    Tumour Biol; 2001; 22(5):328-36. PubMed ID: 11553864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder.
    Hussain SA; Ganesan R; Hiller L; Cooke PW; Murray P; Young LS; James ND
    Oncol Rep; 2003; 10(3):571-6. PubMed ID: 12684626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity.
    Laitinen KL; Soini Y; Mattila J; Pääkkö P
    Cancer; 2000 Apr; 88(7):1590-8. PubMed ID: 10738217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival.
    Korkolopoulou P; Lazaris ACh; Konstantinidou AE; Kavantzas N; Patsouris E; Christodoulou P; Thomas-Tsagli E; Davaris P
    Eur Urol; 2002 Mar; 41(3):274-83. PubMed ID: 12180228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy.
    Cooke PW; James ND; Ganesan R; Burton A; Young LS; Wallace DM
    BJU Int; 2000 May; 85(7):829-35. PubMed ID: 10792161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular apoptosis, proliferation and bcl-2 Bax expression in colorectal carcinoma and their association with tumor prognosis].
    Li L; Yan L; Liu Z; Wang Z; Wen T; Chen X; Huang G
    Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):614-6, 120. PubMed ID: 11825479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder.
    Uchida T; Minei S; Gao JP; Wang C; Satoh T; Baba S
    Oncol Rep; 2002; 9(2):253-9. PubMed ID: 11836589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer.
    Sultana H; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Sato S; Kamazawa S; Ohwada M; Suzuki M; Terakawa N
    Ann Oncol; 2003 Feb; 14(2):214-9. PubMed ID: 12562647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced apoptosis and p53, BCL-2 and BAX expression in breast cancer tissues in vivo and in fibroblast cells in vitro.
    Suzuki K; Kazui T; Yoshida M; Uno T; Kobayashi T; Kimura T; Yoshida T; Sugimura H
    Jpn J Clin Oncol; 1999 Jul; 29(7):323-31. PubMed ID: 10470656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of the bcl-2 and bax oncoprotein in TCC and its clinical significances].
    Yang B; Gu F; Wang X
    Zhonghua Wai Ke Za Zhi; 1997 Oct; 35(10):602-4. PubMed ID: 10678049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.
    Pollack A; Wu CS; Czerniak B; Zagars GK; Benedict WF; McDonnell TJ
    Clin Cancer Res; 1997 Oct; 3(10):1823-9. PubMed ID: 9815569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities.
    Sarbia M; Stahl M; Fink U; Willers R; Seeber S; Gabbert HE
    Clin Cancer Res; 1998 Dec; 4(12):2991-7. PubMed ID: 9865911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.